Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.
about
Prospects for vaccine prevention of meningococcal infectionClinical features and outcome of sporadic serogroup W135 disease Taiwan.Emergence of W135 meningococcal meningitis in Ghana.Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters.Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis.Interlaboratory comparison of PCR-based methods for detection of penicillin G susceptibility in Neisseria meningitidis.Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: increasing prevalence of penicillin nonsusceptibilityMolecular genetic methods in diagnosis and direct characterization of acute bacterial central nervous system infections.Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in BrazilGenomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidisNeisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil.Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin.Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains.Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.Neisseria meningitidis infection: who, when and where?A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017.Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America.Meningococcal carriage during a clonal meningococcal B outbreak in France.Neisseria adhesin A variation and revised nomenclature scheme.Travel-related Neisseria meningitidis serogroup W135 infection, France.Evolution of Sequence Type 4821 Clonal Complex Meningococcal Strains in China from Prequinolone to Quinolone Era, 1972-2013.Antimicrobial susceptibility, serotype and genotype distribution of meningococci in Portugal, 2001-2002.
P2860
Q24537338-6CA3492E-523B-4CFD-A9B6-1FAED4CDF347Q25257271-D6E0D87C-FDE1-4187-A0EA-9AD9C58099FDQ33229682-BC4E7E5B-24CE-42E9-A37C-A9D5B3851EF7Q33769150-E489452F-D5CC-448C-85EF-681D16BA4DA9Q34108549-3D31298B-671D-4399-8C1D-709BA2C8D925Q34231743-FDF32056-2AA8-4845-879C-19B6A35A1E4EQ34231871-5651E4F7-3501-4DCD-B5C5-7EDF8393D569Q34509627-100B7EBE-95E8-4410-84EB-E74A88F654FDQ34618580-14E5E74B-2928-4190-B7F7-35F703ADAB47Q35153843-8C943F49-CF41-45F5-85B8-698399211728Q35794798-914588C1-796A-4289-8D6D-0255E4A3CD57Q35912710-A97F56A4-3B55-44A8-80A2-42DD6B6DA521Q35941460-3970F143-374C-4BD4-A44F-E104596AD7A9Q36028532-65790C32-F9EA-49D5-8361-F45ECF7EE584Q36244108-CCC0A2CD-62F0-44B4-AC77-73CCE3DF3E01Q36253028-2C51B160-0185-4FE1-9221-152CE1014ECDQ36283061-8AF8180B-C4F8-4A8D-B7E0-3A906CA27085Q36976418-22D6D14F-12ED-4F63-A978-CC3EDCE2DDC0Q37256462-8D9F4D31-FBE1-4178-BCEA-5CB764216F37Q37473667-F2B1C67D-CD6B-4D94-83FC-2C364F8ACA65Q38550405-86BA88ED-D680-41AD-9BC4-1DBFF92AAF97Q41271773-079694BE-DF7F-4B01-8515-2F2DE3C43174Q42215157-05D84684-CEFB-46F7-83B1-B16DED4EA7D1Q42260617-A935939D-427B-4AEB-A321-9389B1A01F68Q42735385-0C670444-9737-4A5B-BCDC-D65C52CFF190Q43088467-4AAF27CD-F945-4E6C-A93F-53BAB5144E4CQ52350769-33F7D73D-AE27-4D5D-9A3F-3CE661F136BAQ52805398-7DACEC8D-26D1-49E7-9D6D-649BA145DFA8
P2860
Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Continuing diversification of ...... ence of the serogroup in 2000.
@en
Continuing diversification of ...... ence of the serogroup in 2000.
@nl
type
label
Continuing diversification of ...... ence of the serogroup in 2000.
@en
Continuing diversification of ...... ence of the serogroup in 2000.
@nl
prefLabel
Continuing diversification of ...... ence of the serogroup in 2000.
@en
Continuing diversification of ...... ence of the serogroup in 2000.
@nl
P2093
P2860
P1476
Continuing diversification of ...... ence of the serogroup in 2000.
@en
P2093
Dario Giorgini
Jean-Michel Alonso
Magaly Ducos-Galand
P2860
P304
P356
10.1128/JCM.42.9.4158-4163.2004
P407
P577
2004-09-01T00:00:00Z